<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="nl">
	<id>https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=mp%3AV2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS</id>
	<title>mp:V2.0.0 testgegevens medicatiegegevens ontvangen WDS - Bewerkingsoverzicht</title>
	<link rel="self" type="application/atom+xml" href="https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=mp%3AV2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS"/>
	<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS&amp;action=history"/>
	<updated>2026-05-27T02:39:57Z</updated>
	<subtitle>Bewerkingsoverzicht voor deze pagina op de wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS&amp;diff=131034&amp;oldid=prev</id>
		<title>Marijke van Geijn op 2 sep 2022 om 13:27</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS&amp;diff=131034&amp;oldid=prev"/>
		<updated>2022-09-02T13:27:54Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 2 sep 2022 13:27&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l3&quot;&gt;Regel 3:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 3:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;__NUMBEREDHEADINGS__&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;__NUMBEREDHEADINGS__&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario&#039;s]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Inleiding ==  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Inleiding ==  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS&amp;diff=107390&amp;oldid=prev</id>
		<title>Marijke van Geijn op 4 apr 2022 om 11:32</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS&amp;diff=107390&amp;oldid=prev"/>
		<updated>2022-04-04T11:32:31Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 4 apr 2022 11:32&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Regel 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (WDS)}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (WDS)}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{IssueBox|Deze pagina is nog in bewerking}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;__NUMBEREDHEADINGS__&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;__NUMBEREDHEADINGS__&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l78&quot;&gt;Regel 78:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 76:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| Datum||Omschrijving&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| Datum||Omschrijving&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;| &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2022-04-05&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;| &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;publicatie&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS&amp;diff=96306&amp;oldid=prev</id>
		<title>Marijke van Geijn op 28 feb 2022 om 10:49</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS&amp;diff=96306&amp;oldid=prev"/>
		<updated>2022-02-28T10:49:58Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 28 feb 2022 10:49&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l54&quot;&gt;Regel 54:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 54:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset11-11-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset11&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-11-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-11-1}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-11-1}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-11-2}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-11-2}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-11-3}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-11-3}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l67&quot;&gt;Regel 67:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 67:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset13-13-3 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset13&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-13-3 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset13-13-3}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset13&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-13-3}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS&amp;diff=95808&amp;oldid=prev</id>
		<title>Marijke van Geijn: Nieuwe pagina aangemaakt met &#039;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (WDS)}}  {{IssueBox|Deze pagina is nog in bewerking}}  __NUMBERE...&#039;</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_WDS&amp;diff=95808&amp;oldid=prev"/>
		<updated>2022-02-08T14:56:20Z</updated>

		<summary type="html">&lt;p&gt;Nieuwe pagina aangemaakt met &amp;#039;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (WDS)}}  {{IssueBox|Deze pagina is nog in bewerking}}  __NUMBERE...&amp;#039;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nieuwe pagina&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (WDS)}}&lt;br /&gt;
&lt;br /&gt;
{{IssueBox|Deze pagina is nog in bewerking}}&lt;br /&gt;
&lt;br /&gt;
__NUMBEREDHEADINGS__&lt;br /&gt;
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]&lt;br /&gt;
&lt;br /&gt;
== Inleiding == &lt;br /&gt;
Dit document biedt de mogelijkheid voor het testen van de systeemrol:&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;M&amp;#039;&amp;#039;&amp;#039;edicatie&amp;#039;&amp;#039;&amp;#039;G&amp;#039;&amp;#039;&amp;#039;egevens &amp;#039;&amp;#039;&amp;#039;O&amp;#039;&amp;#039;&amp;#039;ntvangend systeem (MP-MGO) &amp;#039;&amp;#039;&amp;#039;wisselenddoseerschema&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
&lt;br /&gt;
De doelgroep van dit document is de leverancier die &amp;#039;&amp;#039;&amp;#039;zelfstandig testen uitvoert ter voorbereiding op de kwalificatie&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
&amp;lt;br&amp;gt; Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). &amp;lt;br&amp;gt;&lt;br /&gt;
Deze aanpassingen worden vermeld in de documenthistorie.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl&lt;br /&gt;
&lt;br /&gt;
== Uit te voeren stappen ==&lt;br /&gt;
&lt;br /&gt;
Voer – voor ieder scenario in de &amp;#039;Scenarioset&amp;#039; hoofdstukken – de volgende stappen uit:&lt;br /&gt;
# De simulator verstuurt een ‘Medicatiegegevens sturen’ bericht voor de persoon genoemd in Persoonsgegevens.&lt;br /&gt;
# Ontvang het ‘Medicatiegegevens sturen’ bericht en toon de gegevens uit het bericht op het scherm.&lt;br /&gt;
# Beantwoord de kwalificatiesimulator met een ‘ontvangstbevestiging’ bericht.&lt;br /&gt;
&lt;br /&gt;
== Leeswijzer ==&lt;br /&gt;
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:&lt;br /&gt;
# Scenario’s&lt;br /&gt;
# Inhoudelijke gegevens&lt;br /&gt;
&lt;br /&gt;
===Scenario&amp;#039;s===&lt;br /&gt;
In deze paragraaf zijn alle scenario&amp;#039;s van het betreffende hoofdstuk beschreven. &amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
De kolom &amp;#039;beschrijving&amp;#039; geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.&amp;lt;br&amp;gt;&lt;br /&gt;
Bij elk scenario staan de id&amp;#039;s van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf &amp;quot;Inhoudelijke gegevens&amp;quot; van het betreffende hoofdstuk.&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier ontvangt als medicatiegegevens ontvangend systeem. Dit zijn de gegevens voor wisselenddoseerschema.&lt;br /&gt;
&lt;br /&gt;
=== Gebruikersschermen===&lt;br /&gt;
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.&lt;br /&gt;
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.&lt;br /&gt;
&lt;br /&gt;
===Datum T===&lt;br /&gt;
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.&amp;lt;br&amp;gt;&lt;br /&gt;
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} &amp;#039;&amp;#039;&amp;#039;tot en met&amp;#039;&amp;#039;&amp;#039; einddatum {23:59:59}.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 11: wisselenddoseerschema - diversen ==&lt;br /&gt;
=== Scenario’s ===&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|overview-MGR-11}}&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset11-11-1 }}&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-11-1}}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-11-2}}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-11-3}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 13: relatie contact en episode ==&lt;br /&gt;
=== Scenario’s ===&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|overview-MGR-13}}&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset13-13-3 }}&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset13-13-3}}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Documenthistorie ==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D;; color: white; text-align:left;&amp;quot; &lt;br /&gt;
| Datum||Omschrijving&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;br /&gt;
|style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
|style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;color: #B5B5B5;&amp;quot;&amp;gt;&lt;br /&gt;
Deze pagina maakt gebruik van diverse sections uit addendum &amp;#039;database&amp;#039;: [[mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_WDS_addendum|&amp;lt;font style=&amp;quot;color: #B5B5B5;&amp;quot;&amp;gt;&amp;#039;&amp;#039;testgegevens medicatiegegevens MGS/MGO wisselend doseerschema addendum&amp;#039;&amp;#039;&amp;lt;/font&amp;gt;]]. &amp;lt;/font&amp;gt;&lt;/div&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
</feed>